ResBiotic

Vestavia Hills, United States

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.

$8.0M raised

Sep 2025

Series A

Top Investors

Biostack VenturesSororibus CapitalTimberline Investments

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ResBiotic raised?

ResBiotic has raised $8.0M in total funding. The most recent round was Series A. The last funding was announced in September 2025.

Who are ResBiotic's investors?

ResBiotic's investors include Biostack Ventures, Sororibus Capital, Timberline Investments.

Where is ResBiotic headquartered?

ResBiotic is headquartered in Vestavia Hills, United States.

What does ResBiotic do?

ResBiotic develops probiotic and pharmabiotic therapies to alleviate neutrophilic inflammation associated with dysbiosis.

What stage is ResBiotic at?

ResBiotic is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 12, 2025.

MLA

"ResBiotic — Funding & Investors." VCBacked, September 12, 2025, https://www.vcbacked.co/company/resbiotic. Accessed June 17, 2026.

APA

VCBacked. (2025). ResBiotic — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/resbiotic

Wikipedia (cite web)

{{cite web |title=ResBiotic — Funding & Investors |url=https://www.vcbacked.co/company/resbiotic |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 12, 2025.